Biomarkers with high sensitivity and specificity in multiple panels include RUNX3, SOX1, IRF8, and DAPK; these were used specifically for diagnosis of bladder cancer (Supplemental Figure S3). Here, IRF8 is linked to urinary bladder carcinoma.